Referral for liver transplant following acute variceal bleeding: a multicenter cohort study.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
medline:
13
3
2024
pubmed:
13
3
2024
entrez:
13
3
2024
Statut:
aheadofprint
Résumé
Referral for liver transplant (LT) following acute variceal bleeding (AVB) varies widely. We aimed to characterize and assess its impact on clinical outcomes. Observational retrospective cohort including cirrhosis patients with AVB from 3 hospitals in Lisbon, Portugal, from 2018 to 2019. Primary exposure was referral for LT and primary endpoint was all-cause mortality within 2 years of index hospital admission. Among 143 patients, median (IQR) age was 59 (52-72) years and 90 (62.9%) were males. Median (IQR) MELDNa scores on hospital admission and discharge were 15 (11-21) and 13 (10-16), respectively. Overall, 30 (21.0%) patients were assessed for LT, 13 (9.1%) prior to and 17 (11.9%) within 2 years of hospital admission. Overall, 58 (40.6%) patients had at least one potential contra-indication for transplant. LT was performed in 3 (2.1%) patients (among 5 listed). Overall, 34 (23.8%) and 62 (43.4%) patients died at 6 weeks and 2 years post hospital admission, respectively. Following adjustment for confounders, referral for LT was associated with lower 2-year mortality (aHR (95% CI) = 0.20 (0.05-0.85)). In a multicenter cohort of cirrhosis patients with AVB, less than a quarter underwent formal LT evaluation. Improved referral for LT following AVB may benefit cirrhosis patients' longer-term mortality.
Identifiants
pubmed: 38477864
doi: 10.1097/MEG.0000000000002749
pii: 00042737-990000000-00312
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Kovacs TOG, Jensen DM. Varices: esophageal, gastric, and rectal. Clin Liver Dis 2019; 23:625–642.
Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652–659.
Amitrano L, Guardascione MA, Manguso F, Bennato R, Bove A, DeNucci C, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol 2012; 107:1872–1878.
Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014; 146:412–19.e3.
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63:743–752.
Balcar L, Mandorfer M, Hernández-Gea V, Procopet B, Meyer EL, Giráldez A, et al. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding. J Hepatol 2023; 80:73–81.
Altamirano J, Zapata L, Agustin S, Muntaner L, González-Angulo A, Ortiz AL, et al. Predicting 6-week mortality after acute variceal bleeding: role of Classification and Regression Tree analysis. Ann Hepatol 2009; 8:308–315.
Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, et al. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci 2019; 64:1335–1345.
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65:310–335.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69:406–460.
Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014; 59:1144–1165.
Cardoso FS, Bagulho L, Coelho JS, Lamelas J, Mateus E, Mendes M, et al. The impact of donor risk index, recipients’ and operative characteristics on post liver transplant one-year graft failure: a cohort analysis. GE Port J Gastroenterol 2022; 30:275–282.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310:2191–2194.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014; 12:1495–1499.
Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, et al. Factors associated with liver transplant referral among patients with cirrhosis at multiple safety-net hospitals. JAMA Netw Open 2023; 6:e2317549.
Kanwal F, Hernaez R, Liu Y, Taylor TJ, Rana A, Kramer JR, et al. Factors Associated with access to and receipt of liver transplantation in veterans with end-stage liver disease. JAMA Intern Med 2021; 181:949–959.
Bryce CL, Angus DC, Arnold RM, Chang CC, Farrell MH, Manzarbeitia C, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009; 9:2092–2101.
Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, et al.; PREDICT STUDY group of the EASL-CLIF Consortium. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol 2020; 73:842–854.
Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, et al. Evaluation of early vs standard liver transplant for alcohol-associated liver disease. JAMA Surg 2021; 156:1026–1034.
Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10:166–73, 173.e1.